GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

Specialty pharmaceutical firm for rare diseases and unmet medical needs.

GENIL | IS

Overview

Corporate Details

ISIN(s):
TREGENL00016 (+1 more)
LEI:
789000A4NW6W4D8Z4H25
Country:
Türkiye
Address:
MUSTAFA KEMAL MAH. 2119. SOK. NO;3 D:2-3 ÇANKAYA/ANKARA, 06520 ANKARA

Description

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. is a specialty pharmaceutical company established in 1998 that provides solutions for rare diseases and unmet medical needs. The company operates a GMP-certified manufacturing facility and an R&D center to develop, produce, and supply a wide range of products for international markets. Its business model combines strategic partnerships with global firms and in-house innovation to address complex health challenges, leveraging over 25 years of experience in its specialized therapeutic areas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-04-15 14:59
State Supply Office Tender Notification
Turkish 19.3 KB
2025-04-08 15:23
Genel Kurul Tescili
English 442.5 KB
2025-04-08 15:23
Genel Kurul Tescili
Turkish 222.1 KB
2025-04-08 15:23
Genel Kurul Tescili
Turkish 14.9 KB
2025-04-08 15:05
2024 Yılı Analist Sunumu
Turkish 4.6 MB
2025-04-08 15:05
2024 Yılı Analist Sunumu
English 17.0 KB
2025-04-03 17:10
Participation Finance Principles Information Form
English 53.5 KB
2025-03-28 08:40
Pay Geri Alım Programının Yenilenmesi
Turkish 10.9 KB
2025-03-27 15:47
2025 Yılı Karının Belirlenmesi
Turkish 358.5 KB
2025-03-27 15:47
2025 Yılı Karının Belirlenmesi
Turkish 36.0 KB
2025-03-27 11:32
Decision On Our Company's Audit Firm
English 29.5 KB
2025-03-27 11:19
2024 Hesap Dönemi Olağan Genel Kurul Toplantısı Sonuçları
English 442.5 KB
2025-03-27 11:19
2024 Hesap Dönemi Olağan Genel Kurul Toplantısı Sonuçları
Turkish 222.1 KB
2025-03-27 11:19
2024 Hesap Dönemi Olağan Genel Kurul Toplantısı Sonuçları
Turkish 13.6 KB
2025-03-25 09:29
Solar Power Plant Project Update
Turkish 20.6 KB

Automate Your Workflow. Get a real-time feed of all GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.